ABC Business Summary

Allied Biotech Corporation (ticker 1780.TWO) is a leading global manufacturer of carotenoids, specializing in the research, development, and large-scale production of high-value formulations for the food, dietary supplement, and animal feed industries. The company generates revenue primarily through the wholesale of its proprietary "Altratene" brand, which includes a comprehensive suite of products such as beta-carotene, lutein, lycopene, canthaxanthin, and beta-apo-8'-carotenal. These products are utilized as natural colorants and nutritional ingredients in diverse applications ranging from beverages and baked goods to aquaculture and poultry feed. Allied Biotech operates a vertically integrated model from its headquarters in Taipei and its primary manufacturing facility in the Guanyin Industrial Park, Taoyuan. As of 2026, the company maintains a significant market position as the top carotenoid producer in Asia and the third-largest globally, competing directly with multinational giants such as BASF SE, dsm-firmenich, Kemin Industries, and Lycored Ltd. The leadership of Allied Biotech is anchored by Chief Executive Officer and Director Qing Hui Lin, who oversees the firm’s global expansion and strategic R&D initiatives. The company was established in 2001 and has been guided by a veteran board, with Cheng-Li Yang historically serving as Chairman, providing long-term stability and industry expertise. The executive team is characterized by a deep pedigree in precision chemical engineering and biotechnology, focusing on microencapsulation and stabilization technologies to maintain a competitive edge in product shelf-life and bioavailability. Allied Biotech is a publicly traded entity on the Taipei Exchange (TPEx) and has historically attracted investment from institutional players focused on the intersection of specialty chemicals and wellness-driven nutraceuticals.